| Source | Code | Name | Case count | Share of cases (%) |
|---|---|---|---|---|
| REIMB | REIMB_KELA(317)_ICD10(L20) | Topical pimecrolimus and tacrolimus, Atopic dermatitis | 2156 | |
| REIMB | REIMB_KELA(317)_ICD10(L200) | Topical pimecrolimus and tacrolimus, Besnier's prurigo | 1235 | |
| REIMB | REIMB_KELA(134)_ICD10(L400) | General erythroderma, Psoriasis vulgaris | 219 | |
| REIMB | REIMB_KELA(134)_ICD10(L26) | General erythroderma, Exfoliative dermatitis | 102 | |
| REIMB | REIMB_KELA(395)_ICD10(L200) | Dupilumab, Besnier's prurigo | 80 | |
| REIMB | REIMB_KELA(395)_ICD10(L20) | Dupilumab, Atopic dermatitis | 77 | |
| REIMB | REIMB_KELA(134)_ICD9(NA) | General erythroderma, Name not found | 75 | |
| REIMB | REIMB_KELA(134)_ICD10(L20) | General erythroderma, Atopic dermatitis | 59 | |
| REIMB | REIMB_KELA(395)_ICD10(J45) | Dupilumab, Asthma | 39 | |
| REIMB | REIMB_KELA(134)_ICD8(NA) | General erythroderma, Name not found | 24 | |
| REIMB | REIMB_KELA(395)_ICD10(J33) | Dupilumab, Nasal polyp | 24 | |
| REIMB | REIMB_KELA(134)_ICD10(L200) | General erythroderma, Besnier's prurigo | 20 | |
| REIMB | REIMB_KELA(317)_ICD10(L209) | Topical pimecrolimus and tacrolimus, Atopic dermatitis, unspecified | 17 | |
| REIMB | REIMB_KELA(134)_ICD9(6961A) | General erythroderma, Psoriasis and similar disorders, Other psoriasis | 15 | |
| REIMB | REIMB_KELA(395)_ICD10(J330) | Dupilumab, Polyp of nasal cavity | 12 | |
| REIMB | REIMB_KELA(134)_ICD10(NA) | General erythroderma, Name not found | 10 | |
| REIMB | REIMB_KELA(395)_ICD10(J451) | Dupilumab, Nonallergic asthma | 10 | |
| REIMB | REIMB_KELA(395)_ICD10(J450) | Dupilumab, Predominantly allergic asthma | 9 | |
| REIMB | REIMB_KELA(134)_ICD10(L53) | General erythroderma, Other erythematous conditions | 6 |